SCHEMBL899412

SCHEMBL899412

COC1CCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1484812 1.00
SCHEMBL16453950 1.00
Hydrochloric Acid SCHEMBL28032357 0.97
Hydrochloric Acid SCHEMBL11644251 0.97
SCHEMBL11728861 0.97 SLC6A3 (0.33)
SCHEMBL7346006 0.97
SCHEMBL6280246 0.92
SCHEMBL1298622 0.92
SCHEMBL16453949 0.92
SCHEMBL9347890 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103547566-B Aminoindane compounds and their use to treat pain 阿萨纳生物科技有限责任公司 2017-05-31 CN claimed
CN-103547566-A Aminoindane compounds and their use to treat pain ENDO PHARMACEUTICALS INC 2014-01-29 CN claimed
CN-101939326-A Method for producing cycloplatinized platinum complexes, platinum complexes produced by said method, and the use thereof RWTH AACHEN 2011-01-05 CN claimed
CN-115322141-B Method for preparing chiral methylphenidate compound through asymmetric hydrogenation 凯特立斯(深圳)科技有限公司 2024-04-16 CN disclosed
US-20230322777-A1 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors PFIZER INC. (US) 2023-10-12 US disclosed
US-11673890-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2023-06-13 US disclosed
CN-116056698-A Substituted 1- (3, 3-difluoropiperidin-4-yl) -imidazo [4,5-C ] quinolin-2-one compounds with blood brain barrier penetration capability 钟卫 2023-05-02 CN disclosed
CN-115322141-A Method for preparing chiral methylphenidate compound by asymmetric hydrogenation 凯特立斯(深圳)科技有限公司 2022-11-11 CN disclosed
WO-2021252307-A1 RIPK1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME CORP. (US) 2021-12-16 WO disclosed
US-20210047325-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2021-02-18 US disclosed
CN-108212172-B Catalyst for hydrogenation of pyridine compounds and application thereof 西安凯立新材料股份有限公司 2020-11-27 CN disclosed
US-4053596-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1977-10-11 US disclosed
US-4044040-A HYPERTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1977-08-23 US disclosed
US-4012373-A ANTIINFLAMMATORY, CNS DEPRESSANTS E. R. SQUIBB & SONS, INC. (US) 1977-03-15 US disclosed
US-3998808-A INSECTICIDES, FUNGICIDES VELSICOL CHEMICAL CORPORATION (US) 1976-12-21 US disclosed
US-3984419-A HYPOTENSIVES E. R. SQUIBB & SONS, INC. (US) 1976-10-05 US disclosed
US-3982021-A Compositions for the treatment of coronary diseases containing tetrahydronaphthyloxy-aminopropanols E. R. SQUIBB & SONS, INC. (US) 1976-09-21 US disclosed
US-3951950-A ANTIVIRAL, CARDIOVASCULAR, ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1976-04-20 US disclosed
US-3943149-A HYPOCHOLESTEREMIC, ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1976-03-09 US disclosed
US-3935267-A CARDIOVASCULAR DISORDERS E. R. SQUIBB & SONS, INC. (US) 1976-01-27 US disclosed